The Sydney based regenerative medicine company Regeneus has received ethics approval for its clinical trial of stem cells in patients with knee osteoarthritis. Marketed as Progenza the stem cells are produced from the adipose tissue of a healthy donor. According to a company press release the “off-the-shelf allogeneic stem cell treatment” has the potential to reduce ...
OA stem cells trial gets ethics approval
27 Apr 2015